|
HHS National CLAS Standards Work Group
|
Meeting/ Workshop
|
IHS
|
NIMHD
|
The work group includes subject matter experts in health disparities and health equity who are responsible for advising the development of a business case for the National Standards for Culturally and Linguistically Appropriate Services (CLAS) in Health and Health Care. that will present a compelling evidence base for implementation of the National CLAS Standards in health systems. Its target audience will be health care policymakers, administrators, and other decision-makers, who can leverage its findings to advocate for the implementation of the National CLAS Standards at their organization. Ultimately, the business case can empower health systems to take action toward implementation of the National CLAS Standards.
|
|
HHS National Women's Health Week
|
Public Education Campaign
|
AHRQ, CDC, FDA, HRSA, IHS, OASH, SAMHSA
|
NHLBI, NICHD, OD/DPCPSI/ORWH
|
ORWH supported HHS's National Women's Health Week by releasing NIH-Wide Strategic Plan for Research on the Health of Women 2024-2028,NIH Fact Sheets on Women’s Health Research,Health of Women of U3 (Underrepresented, Underserved, and Underreported in biomedical research) Populations Data Book,Annual Vivian W. Pinn Symposium,Future Directions in Menopause Research: Optimizing Midlife Health of Women Roundtable
|
|
HHS Noise-Induced Hearing Loss Federal Partner Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIDCD
|
Work group to coordinate and collaborate HHS activities and messages related to noise-induced hearing loss. Federal partners include NIH (National Institute on Deafness and Other Communication Disorders) and CDC (National Center for Environmental Health and National Institute for Occupational Safety and Health).
|
|
HHS Nursing Council (HHSNC)
|
Committee, Work group, Advisory group, or Task Force
|
USPHS, ACF, ACL, AHRQ, ASPR, ATSDR, CDC, CMS, FDA, HRSA
|
CC, NINR
|
The purpose of the HHSNC is to provide a forum for nurse leaders within the 12 operating divisions of the Department of Health and Human Services (HHS) to inform and collaborate on projects and initiatives that advance the health and well-being of the nation. The HHSNC complements existing groups across HHS, including the National Advisory Council on Nurse Education and Practice, serves as the unifiedvoice of federal civilian and USPHS Commissioned Corps nurses, and advises on current topics that are relevant to HHS nurses and the national and global nursing communities.
|
|
HHS Nutrition Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OASH
|
NCI, NHLBI, NIDCR, OD/DPCPSI/ONR
|
This HHS interagency group meets frequently to discuss topics and issues that are pertinent to the implementation of the Biden-Harris National Strategy on Hunger, Nutrition, and Health. This group also helped develop the framework for the White House Conference on Hunger, Nutrition, and Health. Since the Biden-Harris Administration hosted the White House Conference on Hunger, Nutrition, and Health and released its National Strategy in September 2022, agencies across the federal government have made progress toward the actions and priorities laid out in the National Strategy. These milestones span the National Strategy's 5 pillars:Pillar 1: Improve food access and affordabilityPillar 2: Integrate nutrition and healthPillar 3: Empower all consumers to make and have access to healthy foodPillar 4: Support physical activity for allPillar 5: Enhance nutrition and food security research
|
|
HHS OASH Initiative to Strengthen Primary Care
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NINR
|
HHS recently launched the Strengthen Primary Health Care Initiative led by OASH. The goal of this initiative is to foster the provision of high-quality and accessible primary care. The initial task is to develop an HHS plan for strengthening primary health care.
|
|
HHS Office on Women's Health, Section on Pregnancy and Newborn Care
|
Committee, Work group, Advisory group, or Task Force
|
OS, SAMHSA
|
NICHD, NIMH
|
The National Institutes of Health (NIH) scientists work together with other Department of Health and Human Services (HHS) experts to develop and review content for HHS public-facing websites, including the womenshealth.gov website.
|
|
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/DPCPSI/OAR
|
The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of the Office of AIDS Research Advisory Council (OARAC). The primary goal of the Panel is to provide HIV care practitioners with recommendations based on current knowledge of antiretroviral drugs (ARVs) used to treat adults and adolescents with HIV in the United States. The Panel reviews new evidence and updates recommendations when needed. These guidelines include recommendations on baseline laboratory evaluations, treatment goals, benefits of ART and considerations when initiating therapy, choice of the initial regimen for ART-naive patients, ARV drugs or combinations to avoid, management of treatment failure, management of adverse effects and drug interactions, and special ART-related considerations in specific patient populations. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl…
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/DPCPSI/OAR
|
This committee has the purpose of updating the U.S. Pediatric HIV treatment guidelines and serves as executive secretary. The Department's Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children (the Panel), a working group of the Office of AIDS Research Advisory Council, reviews new data on an ongoing basis, and provides regular updates to the guidelines. The guidelines are available on the AIDSinfo website. These updated guidelines address the use of combination antiretroviral therapy for HIV-infected infants, children, and adolescents. Guidance on management of adverse events associated with use of antiretroviral drugs in children and a detailed review of information about safety, efficacy, and pharmacokinetics of antiretroviral agents in children is also included. https://aidsinfo.nih.gov/guidelines
|
|
HHS Panel on Prevention and Treatment of Opportunistic Infections in HIV-exposed and HIV-infected Children
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, OD/DPCPSI/OAR
|
This committee has the purpose of updating the U.S. Pediatric opportunistic infection prevention and treatment guidelines for HIV-Exposed and HIV-Infected Children and serves as executive secretary. These guidelines are developed by a panel of specialists in pediatric HIV infection and infectious diseases (the Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children) from the U.S. government and academic institutions. The Panel is a working group of the Office of AIDS Research Advisory Council. For each OI, one or more pediatric specialists with subject-matter expertise reviews the literature for new information since the last guidelines were published, and then proposes revised recommendations for review by the full Panel. After these reviews and discussions, the guidelines undergo further revision, with review and approval by the Panel, and final review and endorsement by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Disease Society (PIDS). The Panel also received input from the American Academy of Pediatrics (AAP). https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
|